Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Korean National Health Information Database study finds metabolic syndrome onset (HR: 1.25, 95% CI: 1.06-1.47) or persistence (1.25, 95% CI: 1.06-1.48) increases MGUS risk; resolution showed no risk increase versus absence.”
Title: Metabolic syndrome and risk of monoclonal gammopathy of undetermined significance: a large Korean cohort study
Authors: Ji Yun Lee, Eun-Jung Jung, Soyean Kwon, Sang-A Kim,, Jeong-Ok Lee, Kyungdo Han, Soo-Mee Bang
You can read the Full Article in Haematologica.
You can find more posts featuring Robert Orlowski on OncoDaily.